Late Relapse After Autologous Hematopoietic Stem Cell Transplantation in AQP4-IgG–Positive NMOSD

Vorasoot N., Blackburn KM., Nguyen L., Bush ML., Jenkins SM., Jitprapaikulsan J., Fryer JP., Irani SR., Flanagan EP., Pittock SJ.

This case series examines long-term outcomes for 2 aquaporin-4-IgG (AQP4-IgG)–positive patients with neuromyelitis optica spectrum disorder (NMOSD) who underwent autologous hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen and rituximab.

DOI

10.1001/jamanetworkopen.2025.5989

Type

Journal article

Publisher

American Medical Association (AMA)

Publication Date

2025-04-21T00:00:00+00:00

Volume

8

Pages

e255989 - e255989

Permalink More information Close